ATE288271T1 - Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung - Google Patents

Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung

Info

Publication number
ATE288271T1
ATE288271T1 AT96925615T AT96925615T ATE288271T1 AT E288271 T1 ATE288271 T1 AT E288271T1 AT 96925615 T AT96925615 T AT 96925615T AT 96925615 T AT96925615 T AT 96925615T AT E288271 T1 ATE288271 T1 AT E288271T1
Authority
AT
Austria
Prior art keywords
enalapril
production
solid formulation
stable solid
water
Prior art date
Application number
AT96925615T
Other languages
English (en)
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24034300&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE288271(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Application granted granted Critical
Publication of ATE288271T1 publication Critical patent/ATE288271T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/401—Proline; Derivatives thereof, e.g. captopril
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/556—Angiotensin converting enzyme inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Vascular Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pyrrole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT96925615T 1995-08-04 1996-07-30 Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung ATE288271T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/511,297 US5573780A (en) 1995-08-04 1995-08-04 Stable solid formulation of enalapril salt and process for preparation thereof
PCT/CA1996/000513 WO1997005881A1 (en) 1995-08-04 1996-07-30 Stable solid formulation of enalapril salt and process for preparation thereof

Publications (1)

Publication Number Publication Date
ATE288271T1 true ATE288271T1 (de) 2005-02-15

Family

ID=24034300

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96925615T ATE288271T1 (de) 1995-08-04 1996-07-30 Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung

Country Status (14)

Country Link
US (2) US5573780A (de)
EP (4) EP0841930B1 (de)
JP (1) JP3290994B2 (de)
AT (1) ATE288271T1 (de)
AU (1) AU697696C (de)
BR (1) BR9609964A (de)
CA (1) CA2166001C (de)
DE (4) DE05076813T1 (de)
DK (1) DK0841930T3 (de)
ES (4) ES2223315T1 (de)
IL (1) IL123185A (de)
NZ (1) NZ313576A (de)
RU (1) RU2161970C2 (de)
WO (1) WO1997005881A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof
RU2140261C1 (ru) * 1997-04-03 1999-10-27 Открытое акционерное общество "АЙ СИ ЭН Лексредства" Твердая лекарственная форма на основе малеата эналаприла
ES2125198B1 (es) * 1997-05-13 1999-11-16 Vita Invest Sa Asociacion a dosis fija de un inhibidor de la enzima convertidora de angiotensina y de un antagonista de los canales de calcio, procedimiento para su preparacion y su utilizacion para el tratamiento de enfermees cardiovasculares.
US6296871B1 (en) * 1998-04-12 2001-10-02 Ranbaxy Laboratories Limited Stable solid pharmaceutical compositions containing enalapril maleate
US6153223A (en) * 1998-06-05 2000-11-28 Watson Pharmaceuticals, Inc. Stabilized pharmaceutical compositions
NZ333206A (en) * 1998-12-08 2000-07-28 Bernard Charles Sherman Solid pharmaceutical compositions comprising a stable magnesium salt of quinapril that acts as a ACE (Angiotensin Converting Enzyme) inhibitor
US6637359B1 (en) * 1998-12-15 2003-10-28 Maritrans Inc. System and method for internally fitting a new inner hull to an existing outer hull to form a rebuilt double hull vessel
US6555551B1 (en) 1999-08-31 2003-04-29 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
US20040157911A1 (en) * 1999-08-31 2004-08-12 Spiridon Spireas Storage-stable and bio-stable formulations of ace inhibitors, and methods for preparation thereof
US20030225124A1 (en) * 1999-08-31 2003-12-04 Spiridon Spireas Stable formulations of ACE inhibitors, and methods for preparation thereof
US6764694B1 (en) * 1999-08-31 2004-07-20 Mutual Pharmaceutical Co., Inc. Stable formulations of ACE inhibitors, and methods for preparation thereof
RU2169005C1 (ru) * 2000-09-08 2001-06-20 Открытое акционерное общество "Химико-фармацевтический комбинат "Акрихин" Фармацевтическая композиция с антигипертензивным действием и способ ее получения
UA78542C2 (en) * 2002-01-15 2007-04-10 Actavis Group Hf Formulations of quinapril and other ace inhibitors
RU2203052C1 (ru) * 2002-02-15 2003-04-27 Нестерук Владимир Викторович Твердая лекарственная форма эналаприла
US20030215526A1 (en) * 2002-03-08 2003-11-20 Scott Stofik Stable formulations of angiotensin converting enzyme (ACE) inhibitors
RU2207869C1 (ru) * 2002-04-04 2003-07-10 Акционерное Курганское общество медицинских препаратов и изделий "Синтез" Фармацевтическая твердая композиция на основе эналаприла малеата и способ ее получения
HRP20140476T1 (hr) 2005-11-17 2014-07-18 Silverstone Pharma Est. Stabilni oblik amorfnih soli perindoprila, postupak njihove pripreme, posebno industrijske pripreme i njihova uporaba u lijeäśenju hipertenzije
EA027787B1 (ru) 2010-06-23 2017-09-29 Крка, Товарна Здравил, Д.Д., Ново Место Пероральные лекарственные формы, содержащие лерканидипин и эналаприл и их фармацевтически приемлемые соли
WO2012085249A2 (en) 2010-12-24 2012-06-28 Krka, D.D., Novo Mesto Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts
CN109350733A (zh) * 2018-06-08 2019-02-19 山东理工职业学院 一种马来酸依那普利片剂的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL58849A (en) * 1978-12-11 1983-03-31 Merck & Co Inc Carboxyalkyl dipeptides and derivatives thereof,their preparation and pharmaceutical compositions containing them
FR2576214B1 (fr) * 1985-01-18 1987-02-20 Synthelabo Compositions pharmaceutiques a base de diltiazem et d'un antihypertenseur
US4743450A (en) * 1987-02-24 1988-05-10 Warner-Lambert Company Stabilized compositions
DE4112014A1 (de) * 1991-04-12 1992-10-15 Thomae Gmbh Dr K Kondensierte diazepinone, verfahren zu ihrer herstellung und diese verbindungen enthaltende mittel zur behandlung von erkrankungen des zentralnervensystems und zur foerderung der cerebralen durchblutung
SI9111842A (sl) * 1991-11-25 1998-04-30 Krka Stabilna formulacija soli enalaprila, postopek za njeno pripravo in njena uporaba
WO1994001093A1 (en) * 1992-07-09 1994-01-20 Merck & Co., Inc. Controlled porosity osmotic enalapril pump
US5573780A (en) * 1995-08-04 1996-11-12 Apotex Usa Inc. Stable solid formulation of enalapril salt and process for preparation thereof

Also Published As

Publication number Publication date
EP0841930A1 (de) 1998-05-20
AU697696C (en) 2006-04-06
RU2161970C2 (ru) 2001-01-20
DE04078149T1 (de) 2005-12-29
ES2264912T1 (es) 2007-02-01
EP0841930B1 (de) 2005-02-02
CA2166001C (en) 2005-12-27
CA2166001A1 (en) 1996-12-05
US5690962A (en) 1997-11-25
ES2223315T1 (es) 2005-03-01
AU697696B2 (en) 1998-10-15
IL123185A0 (en) 1998-09-24
DK0841930T3 (da) 2005-04-25
DE69616072D1 (de) 2001-11-22
ES2245275T1 (es) 2006-01-01
BR9609964A (pt) 1999-02-02
DE69616072T2 (de) 2009-09-10
NZ313576A (en) 1999-05-28
WO1997005881A1 (en) 1997-02-20
US5573780A (en) 1996-11-12
JP3290994B2 (ja) 2002-06-10
ES2236741T3 (es) 2005-07-16
EP1442746A1 (de) 2004-08-04
EP1527780A1 (de) 2005-05-04
IL123185A (en) 2001-08-08
DE05076813T1 (de) 2006-11-30
AU6608496A (en) 1997-03-05
JPH10511103A (ja) 1998-10-27
EP1637142A2 (de) 2006-03-22
DE04076118T1 (de) 2005-02-10
EP1637142A3 (de) 2008-04-02

Similar Documents

Publication Publication Date Title
DE69616072D1 (de) Stabile feste formulierung eines enalaprilsalzes und verfahren zu deren herstellung
TR200000832A2 (tr) Sıkıştırılmış kalıp cisimleri için yoğunlaştırılmış patlayıcı taneler.
DK0801559T3 (da) Fremgangsmåde til fremstilling af orale doseringsformer indeholdende et beta-lactam antibiotikum
KR970703133A (ko) 중합체 매트릭스 중의 활성제의 고용체 형태로서의 활성제 제제의 제조 방법 및 그에 의해 얻어진 활성제 제제(Process for Producing Active Agent Preparations in the Form of a Solid Solution of the Active Agent in a Polymer Matrix and Active Agent Preparations Obtained Thereby)
DK1128815T3 (da) Fremgangsmåde til fremstilling af orale calcium-kompositioner
KR900002769A (ko) 장시간 작용하는 나트륨 디클로페낙의 제제
AU8341691A (en) Stabilized solid chemical compositions
DE50110261D1 (de) Verfahren zur herstellung von nichtionischen tensidgranulaten
KR920003971A (ko) 점안액 조성물
ES2154437T3 (es) Composiciones de poli(alcohol vinilico).
AU3483497A (en) Solid solution of an antifungal agent with enhanced bioavailability
ATE17650T1 (de) Trockenpulverisierte n-acetyl-p-aminophenolzusammensetzungenund verfahren zu deren herstellung.
JPS56155203A (en) Production of carboxyl group-containing polymer material
EP0107086A3 (de) Änderung der Betonerstarrung mit eingekapseltem oberflächenaktiven Mittel
DE69524226D1 (de) Verfahren zum herstellen von fusidinsäuretabletten
ATE72118T1 (de) Pharmazeutische zusammensetzung und verfahren zu ihrer herstellung.
DK1117365T3 (da) Vedhæftningsmiddel til tandproteser
JPS5452718A (en) Preparation of solid pharmaceuticals
JPS56169124A (en) Synthesizing method for ammonia
JPS5233662A (en) Preparation of n2-naphthalenesulfonyl-alginamides and acid addition sa lts thereof
RU94038767A (ru) Способ получения гранулированных органоминеральных сорбентов
RU94046203A (ru) Способ получения 5-дихлорацетил-3,3,6-триметил-9-оксо-1,5-диазабицикло[4,3,0]нонана
JPS572682A (en) Washing method of cell
JPS5410392A (en) Preparation of vinyl chloride polymer
AU2001266091A1 (en) Method for coating basic particle compounds

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EEGN Patent not valid in austria
UEP Publication of translation of european patent specification

Ref document number: 0841930

Country of ref document: EP

REN Ceased due to non-payment of the annual fee
RZN Patent revoked